CORT vs. AGX
CORT (Corcept Therapeutics Incorporated) and AGX (Argan, Inc.) are both stocks. CORT operates in Biotechnology (Healthcare), while AGX operates in Engineering & Construction (Industrials). Over the past 10 years, CORT returned 29.33%/yr vs 34.05%/yr for AGX. At a 0.16 correlation, their price movements are largely independent.
Performance
CORT vs. AGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CORT achieves a 110.72% return, which is significantly higher than AGX's 98.28% return. Over the past 10 years, CORT has underperformed AGX with an annualized return of 29.33%, while AGX has yielded a comparatively higher 34.05% annualized return.
CORT
- 1D
- 0.98%
- 1M
- 40.26%
- YTD
- 110.72%
- 6M
- -11.63%
- 1Y
- 5.36%
- 3Y*
- 46.50%
- 5Y*
- 27.35%
- 10Y*
- 29.33%
AGX
- 1D
- -10.76%
- 1M
- -8.86%
- YTD
- 98.28%
- 6M
- 94.57%
- 1Y
- 156.50%
- 3Y*
- 156.79%
- 5Y*
- 69.15%
- 10Y*
- 34.05%
CORT vs. AGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 110.72% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
AGX Argan, Inc. | 98.28% | 130.61% | 198.31% | 30.24% | -2.01% | -11.64% | 19.15% | 8.62% | -14.32% | -34.26% |
Correlation
The correlation between CORT and AGX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004 | 0.16 |
Fundamentals
CORT:
$7.66B
AGX:
$8.80B
CORT:
$0.41
AGX:
$11.38
CORT:
178.81
AGX:
54.46
CORT:
89.07
AGX:
0.99
CORT:
11.07
AGX:
8.43
CORT:
12.00
AGX:
18.59
CORT:
$769.10M
AGX:
$1.04B
CORT:
$755.64M
AGX:
$217.93M
CORT:
$3.66M
AGX:
$163.99M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. AGX — Risk / Return Rank
CORT
AGX
CORT vs. AGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CORT | AGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.03 | ||
| Sortino ratioReturn per unit of downside risk | -2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.36 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.08 | 6.31 | -6.23 |
| Martin ratioReturn relative to average drawdown | 0.15 | 18.30 | -18.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CORT | AGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.07 | 2.10 | -2.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.37 | 1.37 | -1.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.75 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.05 | +0.06 |
Drawdowns
CORT vs. AGX - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, roughly equal to the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for CORT and AGX.
Loading charts...
Drawdown Indicators
| CORT | AGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.28% | -94.37% | +0.09% |
Max Drawdown (1Y)Largest decline over 1 year | -64.40% | -24.96% | -39.44% |
Max Drawdown (3Y)Largest decline over 3 years | -71.85% | -43.75% | -28.10% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -43.75% | -28.10% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | -54.61% | -17.24% |
Current DrawdownCurrent decline from peak | -35.80% | -16.32% | -19.48% |
Average DrawdownAverage peak-to-trough decline | -53.44% | -48.35% | -5.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.34% | 9.50% | +25.84% |
Volatility
CORT vs. AGX - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 16.41%, while Argan, Inc. (AGX) has a volatility of 17.80%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CORT | AGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.41% | 17.80% | -1.39% |
Volatility (6M)Calculated over the trailing 6-month period | 85.07% | 55.76% | +29.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.73% | 75.04% | +1.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.52% | 50.86% | +23.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.22% | 45.84% | +21.38% |
Dividends
CORT vs. AGX - Dividend Comparison
CORT has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.30%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGX Argan, Inc. | 0.30% | 0.52% | 0.93% | 2.24% | 2.71% | 1.94% | 7.31% | 2.49% | 1.98% | 4.44% | 1.42% | 2.16% |
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CORT vs. AGX - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Argan, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. AGX - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
AGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 61.11M and revenue of 290.95M. Therefore, the gross margin over that period was 21.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
AGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 45.40M and revenue of 290.95M, resulting in an operating margin of 15.6%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
AGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 46.06M and revenue of 290.95M, resulting in a net margin of 15.8%.
Frequently Asked Questions
CORT and AGX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGX has higher volatility (17.80%) compared to CORT (16.41%). In terms of maximum drawdown, CORT dropped -94.28% vs AGX's -94.37%.
AGX currently has the higher Sharpe Ratio (2.10 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CORT and AGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer